Becton, Dickinson and Company BDX

NYSEHealth TechnologyUnited States

$218.03+2.32 (+1.08%)

Market closed· Nov 13, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range: 216.38219.78
52-week range: 140.11219.78

Financial health

– / 5

Analyst view · 19 firms

Buy10 buy · 8 hold · 1 sell

Avg. target $226.23 (+3.8%)

Prices may be delayed and are for informational purposes only - not investment advice.

Becton, Dickinson and Company BDX

NYSEHealth TechnologyUnited States

$218.03+2.32 (+1.08%)

Market closed· Nov 13, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range: 216.38219.78
52-week range: 140.11219.78

Financial health

– / 5

Analyst view · 19 firms

Buy10 buy · 8 hold · 1 sell

Avg. target $226.23 (+3.8%)

Valuation from filings

Calculated from the tables below and the current price ($218.03) · LTM · 2026/6 · 2026-06-30

P/E: 65.87EPS $3.31
P/B: 2.51BV/share $87.03
P/S: 2.72Sales/share $80.14
Return on equity: 3.9%Net income / equity
Net margin: 4.2%Operating margin 10.7%
Free cash flow yield: 5.4%Free cash flow / market cap

Revenue and net income

Fiscal year · $ billions · net margin below

RevenueNet Income

Financial statements

$ millions · Under each value: change against a year earlier

Upgrade to MakklerPRO to see every row.Upgrade to MakklerPRO

Fiscal year	2021	2022	2023	2024	2025	LTM
Income Statement
Revenue	19,131	18,870-1%	19,372+3%	20,178+4%	21,840+8%	22,484
Cost of Revenue
Gross Profit
Operating expenses
Operating Income
EBITDA
Pre-tax income
Income tax (expense) / benefit
Net Income	2,092	1,779-15%	1,484-17%	1,705+15%	1,678-2%	942
Earnings per share ($)
Margins
Gross margin
Operating margin
EBITDA margin
Net margin

Taken from the company's own 10-K and 10-Q filings via the SEC's XBRL data service. The "LTM" column is the last completed fiscal year plus the current year to date, minus the same period a year earlier. Lines a company tags with a non-standard label are left blank rather than filled with an approximation. Not investment advice.